Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States.
Department of Anesthesiology and Critical Care Medicine, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Am J Physiol Lung Cell Mol Physiol. 2024 Jan 1;326(1):L52-L64. doi: 10.1152/ajplung.00196.2023. Epub 2023 Nov 21.
Supplemental O remains a necessary intervention for many premature infants (<34 wk gestation). Even moderate hyperoxia (<60% O) poses a risk for subsequent airway disease, thereby predisposing premature infants to pediatric asthma involving chronic inflammation, airway hyperresponsiveness (AHR), airway remodeling, and airflow obstruction. Moderate hyperoxia promotes AHR via effects on airway smooth muscle (ASM), a cell type that also contributes to impaired bronchodilation and remodeling (proliferation, altered extracellular matrix). Understanding mechanisms by which O initiates long-term airway changes in prematurity is critical for therapeutic advancements for wheezing disorders and asthma in babies and children. Immature or dysfunctional antioxidant systems in the underdeveloped lungs of premature infants thereby heightens susceptibility to oxidative stress from O. The novel gasotransmitter hydrogen sulfide (HS) is involved in antioxidant defense and has vasodilatory effects with oxidative stress. We previously showed that exogenous HS exhibits bronchodilatory effects in human developing airway in the context of hyperoxia exposure. Here, we proposed that exogenous HS would attenuate effects of O on airway contractility, thickness, and remodeling in mice exposed to hyperoxia during the neonatal period. Using functional [flexiVent; precision-cut lung slices (PCLS)] and structural (histology; immunofluorescence) analyses, we show that HS donors mitigate the effects of O on developing airway structure and function, with moderate O and HS effects on developing mouse airways showing a sex difference. Our study demonstrates the potential applicability of low-dose HS toward alleviating the detrimental effects of hyperoxia on the premature lung. Chronic airway disease is a short- and long-term consequence of premature birth. Understanding effects of O exposure during the perinatal period is key to identify targetable mechanisms that initiate and sustain adverse airway changes. Our findings show a beneficial effect of exogenous HS on developing mouse airway structure and function with notable sex differences. HS donors alleviate effects of O on airway hyperreactivity, contractility, airway smooth muscle thickness, and extracellular matrix deposition.
补充氧气仍然是许多早产儿(<34 周妊娠)的必要干预措施。即使是中度高氧(<60%氧气)也会对随后的气道疾病构成风险,从而使早产儿易患涉及慢性炎症、气道高反应性(AHR)、气道重塑和气流阻塞的儿科哮喘。中度高氧通过对气道平滑肌(ASM)的作用促进 AHR,ASM 是一种也导致支气管扩张和重塑受损的细胞类型(增殖、细胞外基质改变)。了解氧气在早产儿中引发长期气道变化的机制对于治疗婴儿和儿童的喘息障碍和哮喘至关重要。早产儿未成熟或功能失调的抗氧化系统使他们更容易受到氧气的氧化应激。新型气体递质硫化氢(HS)参与抗氧化防御,并具有氧化应激时的血管舒张作用。我们之前表明,外源性 HS 在高氧暴露的情况下表现出人类发育中的气道的支气管扩张作用。在这里,我们假设外源性 HS 会减轻新生期高氧暴露小鼠气道收缩性、厚度和重塑的 O 作用。使用功能[flexiVent;精密切割肺切片(PCLS)]和结构(组织学;免疫荧光)分析,我们表明 HS 供体减轻了 O 对发育中气道结构和功能的影响,中度 O 和 HS 对发育中小鼠气道的影响表现出性别差异。我们的研究表明,低剂量 HS 具有减轻高氧对早产儿肺的有害影响的潜在适用性。慢性气道疾病是早产的短期和长期后果。了解围产期氧气暴露的影响对于确定引发和维持不良气道变化的可靶向机制至关重要。我们的研究结果表明,外源性 HS 对发育中小鼠气道结构和功能具有有益影响,并且具有显著的性别差异。HS 供体减轻了 O 对气道高反应性、收缩性、气道平滑肌厚度和细胞外基质沉积的影响。